HEIDELBERG PHARMA AG - DE000A11QVV0 (Stock)
/IBT-BA-HP/WEB-INF/snippets/root/general/name.jsp
0
0
0
4,07 EUR
|
-0,6251% |
21.09.2020 11:10
|
20.000,00 |
3,00 |
3,31 |
20.000,00 |
/IBT-BA-HP/WEB-INF/snippets/root/general/v2/infobar.jsp
0
0
0
/IBT-BA-HP/WEB-INF/snippets/root/general/toolbar.jsp
29
0
29
/IBT-BA-HP/WEB-INF/snippets/root/stock/navigation.jsp
33
0
33
Balance ratios |
2024 |
2023 |
Total assets |
60.720 EUR |
70.353 EUR |
Employees |
116 |
105 |
Cash and cash equivalents |
29.421 EUR |
43.438 EUR |
Intangible / inalienable assets |
8.858 EUR |
8.897 EUR |
Economic shareholder's equity |
30.865 EUR |
49.339 EUR |
Subscribed Capital |
46.604 EUR |
46.604 EUR |
Liabilities |
29.854 EUR |
21.013 EUR |
Liabilities to financial institutions |
- |
- |
GuV Zahlen |
2024 |
2023 |
Sales |
6.849 EUR |
9.858 EUR |
Profit after tax |
-19.381 EUR |
-20.346 EUR |
Deprecation (??) |
871 EUR |
878 EUR |
Dividend ordinary shares |
- |
- |
Net investment income |
0 EUR |
0 EUR |
Dividend preferred shares |
- |
- |
Net interests income |
1.283 EUR |
6.786 EUR |
Earnings from ordinary operating activities |
-19.381 EUR |
-20.346 EUR |
Net income (after minority interests) |
-19.381 EUR |
-20.346 EUR |
Net earnings per share |
-0.42 EUR |
-0.44 EUR |
Total payout |
0 EUR |
0 EUR |
Administrative expenses |
- |
- |